Search results
Author(s):
Tze-Fan Chao
,
Chern-En Chiang
,
Shih-Ann Chen
Added:
3 years ago
Burden of Atrial Fibrillation
Atrial fibrillation (AF) is the most common sustained arrhythmia in clinical practice, accounting for approximately one-third of hospitalisations for cardiac rhythm disturbances.1 Between 1980 and 2000, the age-adjusted incidence of AF significantly increased from 3.04 to 3.68 per 1,000 person-years in the US.2 The prevalence of AF was lower among African Americans…
View more
Nils Kucher
Job title: Professor of Angiology / Director University Clinic of Angiology
Author
Author(s):
Giovanni Luca Botto
,
Giovanni Tortora
,
Maria Carla Casale
,
et al
Added:
2 years ago
Author(s):
Yousif Ahmad
,
Gregory YH Lip
Added:
3 years ago
Atrial fibrillation (AF) leads to a prothrombotic state1 and places patients at risk of thromboembolic disease. The most common and serious complication of thromboembolism is stroke, and AF is held responsible for 25 % of all strokes.2 Strokes in the context of AF are associated with a higher mortality, longer hospital stay and lower levels of independence at discharge.3 These factors combine to…
View more
Christian Ruff
Author
Author(s):
Farhan Shahid
,
Gregory YH Lip
Added:
3 years ago
Atrial fibrillation (AF) and heart failure (HF) are global epidemics that began more than a century ago, and their association with an ageing general population has brought about an increase in cardiovascular morbidity and rising healthcare costs.1,2 More than 50 % of patients with permanent AF have a concurrent diagnosis of HF and this proportion is expected to rise.3 It is well established that…
View more
Author(s):
Naima Maqsood
,
Jeff Healey
Added:
4 months ago
AHA 2023 — Dr Naima Maqsood, CardioNerds ambassador (Temple University Hospital, US) interviews investigator, Dr Jeff Healey (McMaster University, CA) to outline the findings from a phase 4 trial of apixaban to reduce thromboembolism in patients with subclinical atrial fibrillation (AF).ARTESiA (NCT01938248) aims to determine if apixaban in combination with aspirin can reduce the instance of…
View more
Author(s):
Philipp Bushoven
,
Sven Linzbach
,
Mate Vamos
,
et al
Added:
3 years ago
Atrial Fibrillation, Cardioversion and Stroke Risk
Atrial fibrillation (AF) is the most common serious chronic heart rhythm disorder with an estimated prevalence in the general population of around 1%.1 The arrhythmia affects about 2.2 million persons in the US and 4.5 million individuals in the EU. Due to the advancing age of the population, the prevalence of AF is likely to increase even…
View more
Author(s):
Nicolas M Van Mieghem
,
Joost Daemen
Added:
1 year ago
Learn about the key take-home messages from ACC.22 with View from the Thoraxcenter hosts, Professor Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL).
In this succinct review video, they summarise the top late-breaking science trials and share their take on how the new data can be translated into practice.
Trials covered in detail include:
00:29: PACMAN AMI:…
View more
Author(s):
Nicolas M Van Mieghem
,
Joost Daemen
Added:
2 years ago
In this concise episode of View from the Thoraxcenter, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) offer their analysis of the late-breaking trials that will be presented at ACC 2022.
Trials covered in detail include:
00:39: PACMAN AMI: Effects of Alirocumab on Coronary Atherosclerosis Assessed by Serial Multimodality Intracoronary Imaging in Patients…
View more